羟基脲治疗真性红细胞增多症患者红细胞膜蛋白的定量分析

Q4 Biochemistry, Genetics and Molecular Biology EuPA Open Proteomics Pub Date : 2015-06-01 DOI:10.1016/j.euprot.2015.04.001
Darshana Kottahachchi , Lallindra Gooneratne , Anil Jayasekera , Dorota Muth-Pawlak , Robert Moulder , Susumu Y. Imanishi , Ari Ariyaratne , Anne Rokka , Garry L. Corthals
{"title":"羟基脲治疗真性红细胞增多症患者红细胞膜蛋白的定量分析","authors":"Darshana Kottahachchi ,&nbsp;Lallindra Gooneratne ,&nbsp;Anil Jayasekera ,&nbsp;Dorota Muth-Pawlak ,&nbsp;Robert Moulder ,&nbsp;Susumu Y. Imanishi ,&nbsp;Ari Ariyaratne ,&nbsp;Anne Rokka ,&nbsp;Garry L. Corthals","doi":"10.1016/j.euprot.2015.04.001","DOIUrl":null,"url":null,"abstract":"<div><p>More than 90% of polycythemia vera (PV) patients have a mutation in the protein JAK2, which is closely associated with the erythrocyte membrane. With the comparison of 1-D gels of erythrocyte membranes obtained from PV patients treated with hydroxycarbamide and those of untreated controls we observed significant differences in the region of 40–55<!--> <!-->kDa. On the basis of the LC–MS/MS analysis of this region we report up-regulation of four protein disulfide isomerases, which was subsequently confirmed by targeted mass spectrometric analysis. In further studies it will be prudent to compare this in patients both treated and not treated with hydroxycarbamide.</p></div>","PeriodicalId":38260,"journal":{"name":"EuPA Open Proteomics","volume":"7 ","pages":"Pages 43-53"},"PeriodicalIF":0.0000,"publicationDate":"2015-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.euprot.2015.04.001","citationCount":"5","resultStr":"{\"title\":\"Quantitative analysis of the erythrocyte membrane proteins in polycythemia vera patients treated with hydroxycarbamide\",\"authors\":\"Darshana Kottahachchi ,&nbsp;Lallindra Gooneratne ,&nbsp;Anil Jayasekera ,&nbsp;Dorota Muth-Pawlak ,&nbsp;Robert Moulder ,&nbsp;Susumu Y. Imanishi ,&nbsp;Ari Ariyaratne ,&nbsp;Anne Rokka ,&nbsp;Garry L. Corthals\",\"doi\":\"10.1016/j.euprot.2015.04.001\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>More than 90% of polycythemia vera (PV) patients have a mutation in the protein JAK2, which is closely associated with the erythrocyte membrane. With the comparison of 1-D gels of erythrocyte membranes obtained from PV patients treated with hydroxycarbamide and those of untreated controls we observed significant differences in the region of 40–55<!--> <!-->kDa. On the basis of the LC–MS/MS analysis of this region we report up-regulation of four protein disulfide isomerases, which was subsequently confirmed by targeted mass spectrometric analysis. In further studies it will be prudent to compare this in patients both treated and not treated with hydroxycarbamide.</p></div>\",\"PeriodicalId\":38260,\"journal\":{\"name\":\"EuPA Open Proteomics\",\"volume\":\"7 \",\"pages\":\"Pages 43-53\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2015-06-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1016/j.euprot.2015.04.001\",\"citationCount\":\"5\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"EuPA Open Proteomics\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2212968515000100\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Biochemistry, Genetics and Molecular Biology\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"EuPA Open Proteomics","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2212968515000100","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Biochemistry, Genetics and Molecular Biology","Score":null,"Total":0}
引用次数: 5

摘要

超过90%的真性红细胞增多症(PV)患者有JAK2蛋白突变,该蛋白与红细胞膜密切相关。通过比较羟基脲治疗的PV患者和未治疗的对照组的红细胞膜1-D凝胶,我们发现在40-55 kDa区域有显著差异。在此区域LC-MS /MS分析的基础上,我们报道了四种蛋白二硫异构酶的上调,随后通过靶向质谱分析证实了这一点。在进一步的研究中,比较接受羟脲治疗和未接受羟脲治疗的患者将是谨慎的。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

摘要图片

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Quantitative analysis of the erythrocyte membrane proteins in polycythemia vera patients treated with hydroxycarbamide

More than 90% of polycythemia vera (PV) patients have a mutation in the protein JAK2, which is closely associated with the erythrocyte membrane. With the comparison of 1-D gels of erythrocyte membranes obtained from PV patients treated with hydroxycarbamide and those of untreated controls we observed significant differences in the region of 40–55 kDa. On the basis of the LC–MS/MS analysis of this region we report up-regulation of four protein disulfide isomerases, which was subsequently confirmed by targeted mass spectrometric analysis. In further studies it will be prudent to compare this in patients both treated and not treated with hydroxycarbamide.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
EuPA Open Proteomics
EuPA Open Proteomics Biochemistry, Genetics and Molecular Biology-Biochemistry
自引率
0.00%
发文量
0
审稿时长
103 days
期刊最新文献
Proceedings of the EuBIC-MS 2020 Developers’ Meeting Editorial: The next generation in (EuPA Open) Proteomics Aims & scope Proceedings of the EuBIC Winter School 2019 Introducing the YPIC challenge
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1